Gene Center Munich

Breadcrumb Navigation


Theurich Lab - Publications

Preprints   |   2024   |   2023  |   2022   |   2021   |   2020   |   2019   |   2018   |   2017   |   2016   |   2015   |   2014   |   2013   |   2012   |   2011   |  2009  and before


P2Y6 receptor signaling in natural killer cells impairs insulin sensitivity in obesity
Anna Sieben, Anne Christine Hausen, Paul Klemm, Alexander Jais, Christian Heilinger, Jens Alber, Kat Folz-Donahue, Lena Schumacher, Janine Altmüller, Marek Franitza, Patrick Giavalisco, Yvonne Hinze, Susanne Brodesser, Christian Kukat, Sebastian Theurich, Jens C. Brüning
bioRxiv 2021.06.23.449596;

Acute exercise induces natural killer cell mobilization but not infiltration into prostate cancer tissue in humans
A Schenk, T Esser, S Belen, N Gunasekara, N Joisten, M Winker, L Weike, W Bloch, A Heidenreich, J Herden, H Löser, S Oganesian, S Theurich, C Watzl, P Zimmer
medRxiv 2022.04.28.22274307;


Post-transplant-cyclophosphamide and short-term Everolimus as graft-versus-host-prophylaxis in patients with relapsed/refractory lymphoma and myeloma-Final results of the phase II OCTET-EVER trial.
Richardson T, Scheid C, Herling M, Frenzel LP, Herling C, Aguilar MRC, Theurich S, Hallek M, Holtick U.
Eur J Haematol. 2024 Apr 14. doi: 10.1111/ejh.14210. Online ahead of print.
PMID: 38616351

Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma.
Stock S, Fertig L, Gottschlich A, Dörr J, Märkl F, Majed L, Menkhoff VD, Grünmeier R, Rejeski K, Cordas Dos Santos DM, Theurich S, von Bergwelt-Baildon M, Endres S, Subklewe M, Kobold S.
Cancer Immunol Immunother. 2024 Apr 17;73(6):100. doi: 10.1007/s00262-024-03688-4.
PMID: 38630291 Free PMC article.

Exercise Therapy in Oncology—the Impact on Quality of Life and Side Effects.
Baumann FT, Jensen W, Berling-Ernst A, Theurich S, Leitzmann M, Götte M.
Dtsch Arztebl Int. 2024 May 3;(Forthcoming):arztebl.m2024.0038. doi: 10.3238/arztebl.m2024.0038. Online ahead of print. PMID: 38509786 Review.

Inhibitory CARs fail to protect from immediate T cell cytotoxicity.
Funk MA, Heller G, Waidhofer-Söllner P, Leitner J, Steinberger P. Mol Ther. 2024 Feb 22:S1525-0016(24)00091-1. doi: 10.1016/j.ymthe.2024.02.022.


Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1α-mediated glycolytic reprogramming.
Wu H, Zhao X, Hochrein SM, Eckstein M, Gubert GF, Knöpper K, Mansilla AM, Öner A, Doucet-Ladevèze R, Schmitz W, Ghesquière B, Theurich S, Dudek J, Gasteiger G, Zernecke A, Kobold S, Kastenmüller W, Vaeth M. Nat Commun. 2023 Oct 27;14(1):6858. doi: 10.1038/s41467-023-42634-3 .PMID: 37891230 Free PMC article.

The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma. Rejeski K, Hansen DK, Bansal R, Sesques P, Ailawadhi S, Logue JM, Bräunlein E, Cordas Dos Santos DM, Freeman CL, Alsina M, Theurich S, Wang Y, Krackhardt AM, Locke FL, Bachy E, Jain MD, Lin Y, Subklewe M.; J Hematol Oncol. 2023 Jul 31;16(1):88. doi: 10.1186/s13045-023-01465-x. PMID: 37525244; PMCID: PMC10391746.

Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults. Chakupurakal G, Freudenberger P, Skoetz N, Ahr H, Theurich S. Cochrane Database Syst Rev. 2023 Jun 21;6(6):CD009159. doi: 10.1002/14651858.CD009159.pub3. PMID: 37341189; PMCID: PMC10284458.

CD33 BiTE® molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells.
Marcinek A, Brauchle B, Rohrbacher L, Hänel G, Philipp N, Märkl F, Strzalkowski T, Lacher SM, Udiljak D, Spiekermann K, Theurich S, Kobold S, Kischel R, James JR, Bücklein VL, Subklewe M.
Cancer Immunol Immunother. 2023 Apr 11. doi: 10.1007/s00262-023-03439-x. Online ahead of print.
PMID: 37041225

Influence of adipose tissue distribution, sarcopenia, and nutritional status on clinical outcomes after CD19 CAR T-cell therapy.
Rejeski K, Cordas Dos Santos DM, Parker NH, Bücklein VL, Winkelmann M, Jhaveri KS, Liu L, Trinkner P, Günther S, Karschnia P, Blumenberg V, Schmidt C, Kunz WG, von Bergwelt-Baildon M, Jain MD, Theurich S, Subklewe M.
Cancer Immunol Res. 2023 Apr 11:CIR-22-0487. doi: 10.1158/2326-6066.CIR-22-0487. Online ahead of print.
PMID: 37040425

Survival and immunotoxicities in association with sex-specific body composition patterns of cancer patients undergoing immune-checkpoint inhibitor therapy - A systematic review and meta-analysis.
Trinkner P, Günther S, Monsef I, Kerschbaum E, von Bergwelt-Baildon M, Cordas Dos Santos DM, Theurich S.
Eur J Cancer. 2023 Feb 18;184:151-171. doi: 10.1016/j.ejca.2023.01.030. Online ahead of print.
PMID: 36931074 Review.

Exercise interventions for adults with cancer receiving radiation therapy alone.
Trommer M, Marnitz S, Skoetz N, Rupp R, Niels T, Morgenthaler J, Theurich S, von Bergwelt-Baildon M, Baues C, Baumann FT.
Cochrane Database Syst Rev. 2023 Mar 13;3(3):CD013448. doi: 10.1002/14651858.CD013448.pub2.
PMID: 36912791 Review.

STING agonism turns human T cells into interferon-producing cells but impedes their functionality.
Kuhl N, Linder A, Philipp N, Nixdorf D, Fischer H, Veth S, Kuut G, Xu TT, Theurich S, Carell T, Subklewe M, Hornung V.
EMBO Rep. 2023 Jan 27:e55536. doi: 10.15252/embr.202255536.

Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis.
Bodensohn R, Werner S, Reis J, Pazos Escudero M, Kaempfel AL, Hadi I, Forbrig R, Manapov F, Corradini S, Belka C, Theurich S, Heinzerling L, Schlaak M, Niyazi M.
Clin Transl Radiat Oncol. 2023 Jan 4;39:100573. doi: 10.1016/j.ctro.2022.100573.



Risk Stratification Based on a Pattern of Immunometabolic Host Factors Is Superior to Body Mass Index-Based Prediction of COVID-19-Associated Respiratory Failure.
Cordas Dos Santos DM, Liu L, Gerisch M, Hellmuth JC, von Bergwelt-Baildon M, Kunz WG, Theurich S., Nutrients. 2022 Oct 13;14(20):4280. doi: 10.3390/nu14204280.PMID: 36296963 Free PMC article.

Interdisziplinäres Symposium "Kutane Lymphome in Klinik und Praxis".
Klemke CD, Theurich S., J Dtsch Dermatol Ges. 2022 Sep;20(9):1281-1282. doi: 10.1111/ddg.14880_g.PMID: 36162027 No abstract available.

Usability of German hospital administrative claims data for healthcare research: General assessment and use case of multiple myeloma in Munich university hospital in 2015-2017.
AlZahmi A, Cenzer I, Mansmann U, Ostermann H, Theurich S, Schleinkofer T, Berger K., PLoS One. 2022 Jul 28;17(7):e0271754. doi: 10.1371/journal.pone.0271754. eCollection 2022.PMID: 35901025 Free PMC article.

Distinct distribution patterns of exercise-induced natural killer cell mobilization into the circulation and tumor tissue of patients with prostate cancer
Schenk A, Esser T, Belen S, Gunasekara N, Joisten N, Winker MT, Weike L, Bloch W, Heidenreich A, Herden J, Löser H, Oganesian S, Theurich S, Watzl C, Zimmer P.
Am J Physiol Cell Physiol. 2022 Aug 1. doi: 10.1152/ajpcell.00243.2022.

T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals.
Zieger N, Kazerani M, Nicholls A, Vick B, Wulf J, Straub T, Scheurer M, Muth A, Hänel G, Nixdorf D, Sponheimer M, Ohlmeyer M, Lacher SM, Brauchle B, Marcinek A, Rohrbacher L, Leutbecher A, Rejeski K, Weigert O, von Bergwelt-Baildon M, Theurich S, Kischel R, Jeremias I, Bücklein VL, Subklewe M.
Blood. 2022 Jul 25:blood.2022015956. doi: 10.1182/blood.2022015956

Profound response to venetoclax monotherapy in a patient with BCL-2 positive relapsed multiple myeloma and extramedullary CNS manifestations.
Cordas Dos Santos DM, Paul T, Kunz WG, Rudelius M, Theurich S.
Leuk Lymphoma. 2022 Jul 6:1-5. doi: 10.1080/10428194.2022.2095625

Physical activity in cancer - effectiveness of exercise therapy approaches.
Siebert S, Kersten J, Theurich S, Baumann FT.
Dtsch Med Wochenschr. 2022 Jul;147(13):831-839. doi: 10.1055/a-1685-6919

Checkpoint-inhibitor induced Polyserositis with Edema.
Zierold S, Akcetin LS, Gresser E, Maier AM, König A, Kramer R, Theurich S, Tomsitz D, Erdmann M, French LE, Rudelius M, Heinzerling L.
Cancer Immunol Immunother. 2022 May 16. doi: 10.1007/s00262-022-03211-7

Two-dimensional CT measurements enable assessment of body composition on head and neck CT.
Zopfs D, Pinto Dos Santos D, Kottlors J, Reimer RP, Lennartz S, Kloeckner R, Schlaak M, Theurich S, Kabbasch C, Schlamann M, Große Hokamp N N.Eur Radiol. 2022 Apr 7. doi: 10.1007/s00330-022-08773-9. Epub ahead of print. PMID: 35389049.

Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 CAR-T in advanced B-cell malignancies.
Dos Santos DMC*, Rejeski K*, Winkelmann M, Liu L, Trinkner P, Günther S, Bücklein VL, Blumenberg V, Schmidt C, Kunz WG, Von Bergwelt-Baildon M, Theurich S*, Subklewe M*; *contributed equally
, 2022 Feb 17. doi: 10.3324/haematol.2021.280189. Online ahead of print.PMID: 35172565



Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies
Pflug, Natali; Chakupurakal, Geothy; Fink, Anna-Maria; Robrecht, Sandra; Herling, Marco; Cramer, Paula; Holtick, Udo; Theurich, Sebastian; Schetelig, Johannes; Fischer, Kirsten; Ritgen, Matthias; Scheid, Christof; Eichhorst, Barbara1; Dreger, Peter; Hallek, Michael; von Bergwelt-Baildon, Michael
HemaSphere, 2021 Dec - Volume 5 - Issue 12 - p e664; doi: 10.1097/HS9.0000000000000664

Disrupting Roquin-1 interaction with Regnase-1 induces autoimmunity and enhances antitumor responses
Gesine Behrens, Stephanie L. Edelmann, Timsse Raj, Nina Kronbeck, Thomas Monecke, Elena Davydova, Elaine H. Wong, Lisa Kifinger, Florian Giesert, Martin E. Kirmaier, Christine Hohn, Laura S. de Jonge, Mariano Gonzalez Pisfil, Mingui Fu, Sebastian Theurich, Stefan Feske, Naoto Kawakami, Wolfgang Wurst, Dierk Niessing & Vigo Heissmeyer
Nat Immunol; 2021 Nov 22; DOI:

P2Y6 receptor signaling in natural killer cells impairs insulin sensitivity in obesity
Anna Sieben, Anne Christine Hausen, Paul Klemm, Alexander Jais, Christian Heilinger, Jens Alber, Kat Folz-Donahue, Lena Schumacher, Janine Altmüller, Marek Franitza, Patrick Giavalisco, Yvonne Hinze, Susanne Brodesser, Christian Kukat, Sebastian Theurich, Jens C. Brüning
bioRxiv 2021.06.23 ; doi:

Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306).
Liu L, Erickson NT, Ricard I, von Weikersthal LF, Lerch MM, Decker T, Kiani A, Kaiser F, Heintges T, Kahl C, Kullmann F, Scheithauer W, Link H, Höffkes HG, Moehler M, Gesenhues AB, Theurich S, Michl M, Modest DP, Algül H, Stintzing S, Heinemann V, Holch JW.
Int J Cancer. 2021 Aug 25. doi: 10.1002/ijc.33775.

Pflug N, Vitus M, Knuever J, Hamacher S, Mauch C, Schlaak M, Theurich S. Treatment-specific evaluation of the modified Glasgow-Prognostic-Score in patients with advanced cutaneous melanoma.
J Eur Acad Dermatol Venereol.
2021 Jul 26. doi: 10.1111/jdv.17533. Epub ahead of print.

High-resolution spatiotemporal pH e and pO 2 imaging in head and neck and oesophageal carcinoma cells
Alexandra Blancke Soares, Robert Meier, Gregor Liebsch, Sabina Schwenk-Zieger, Martin E Kirmaier, Sebastian Theurich, Magdalena Widmann, Martin Canis , Olivier Gires, Frank Haubner
Cancer Metab. 2021 May 4;9(1):21. doi: 10.1186/s40170-021-00257-6.

Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMM.
Bachmann F, Schreder M, Engelhardt M, Langer C, Wolleschak D, Mügge LO, Dürk H, Schäfer-Eckart K, Blau IW, Gramatzki M, Liebisch P, Grube M, V Metzler I, Bassermann F, Metzner B, Röllig C, Hertenstein B, Khandanpour C, Dechow T, Hebart H, Jung W, Theurich S, Maschmeyer G, Salwender H, Hess G, Bittrich M, Rasche L, Brioli A, Eckardt KU, Straka C, Held S, Einsele H, Knop S.
Cancers (Basel). 2021 Mar 16;13(6):1322. doi: 10.3390/cancers13061322.

Immature Plasma Cell Myeloma Mimics Metastatic Renal Cell Carcinoma on 18F-PSMA-1007 PET/CT Due to Endothelial PSMA-Expression.
Mittlmeier LM, Ledderose ST, Schott M, Brendel M, Beyer L, Theurich S, Mayr D, Walz C, Kunz WG, Ricke J, Bartenstein P, Ilhan H, Staehler M, Unterrainer M.
Diagnostics (Basel). 2021 Mar 3;11(3):423. doi: 10.3390/diagnostics11030423.

Long-term physical training in adolescent sprint and middle distance swimmers alters the composition of circulating T and NK cells which correlates with soluble ICAM-1 serum concentrations.
Notbohm HL, Schumann M, Fuhrmann S, Klocke J, Theurich S, Bloch W.
Eur J Appl Physiol. 2021 Mar 11. doi: 10.1007/s00421-021-04660-1.



Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany
Monika Engelhardt, Khalid Shoumariyeh, Amelie Rösner, Gabriele Ihorst, Francesca Biavasco, Katharina Meckel, Ivana von Metzler, Sebastian Theurich, Holger Hebart, Matthias Grube, Miriam Kull, Florian Bassermann, Kerstin Schäfer-Eckart, Anette Hoferer, Hermann Einsele, Leo Rasche, Ralph Wäsch
Haematologica, 2020 Dec 1;105(12):2872-2878. doi: 10.3324/haematol.2020.262758

Addition of Radiotherapy to Immunotherapy: Effects on Outcome of Different Subgroups Using a Propensity Score Matching.
Trommer M, Kinsky J, Adams A, Hellmich M, Schlaak M, von Bergwelt-Baildon M, Celik E, Rosenbrock J, Morgenthaler J, Herter JM, Linde P, Mauch C, Theurich S, Marnitz S, Baues C.
Cancers (Basel). 2020 Aug 27;12(9):2429. doi: 10.3390/cancers12092429.
PMID: 32867046 Free PMC article.

Evaluating body composition by combining quantitative spectral detector computed tomography and deep learning-based image segmentation.
Zopfs D, Bousabarah K, Lennartz S, Santos DPD, Schlaak M, Theurich S, Reimer RP, Maintz D, Haneder S, Große Hokamp N.
Eur J Radiol. 2020 Sep;130:109153. doi: 10.1016/j.ejrad.2020.109153. Epub 2020 Jul 12.
PMID: 32717577

Primary and Secondary Prevention of Multiple Myeloma - Lifestyle Factors and Supportive Measures.
Cordas Dos Santos D, Erickson N, Gerland L, Jundt F, Theurich S.
Dtsch Med Wochenschr. 2020 Jun;145(12):836-842. doi: 10.1055/a-1009-1363. Epub 2020 Jun 17.
PMID: 32557486 German.

ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells.
Redondo Monte E, Wilding A, Leubolt G, Kerbs P, Bagnoli JW, Hartmann L, Hiddemann W, Chen-Wichmann L, Krebs S, Blum H, Cusan M, Vick B, Jeremias I, Enard W, Theurich S, Wichmann C, Greif PA.
Oncogene. 2020 Apr;39(15):3195-3205. doi: 10.1038/s41388-020-1209-4. Epub 2020 Mar 2. PMID: 32115572; PMCID: PMC7142018.

Corrigendum: Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition.
Trommer M, Yeo SY, Persigehl T, Bunck A, Grüll H, Schlaak M, Theurich S, von Bergwelt-Baildon M, Morgenthaler J, Herter JM, Celik E, Marnitz S, Baues C.
Front Pharmacol. 2020 Jan 31;10:1615. doi: 10.3389/fphar.2019.01615. Erratum for: Front Pharmacol. 2019 May 14;10:511. PMID: 32082149; PMCID: PMC7006368.

Single-slice CT measurements allow for accurate assessment of sarcopenia and body composition.
Zopfs D, Theurich S, Große Hokamp N, Knuever J, Gerecht L, Borggrefe J, Schlaak M, Pinto Dos Santos D.
Eur Radiol. 2020 Mar;30(3):1701-1708. doi: 10.1007/s00330-019-06526-9. Epub 2019 Nov 27. PMID:

Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy.
Fürstenau M, Hopfinger G, Robrecht S, Fink AM, Al-Sawaf O, Langerbeins P, Cramer P, Tresckow JV, Maurer C, Kutsch N, Hoechstetter M, Dreyling M, Lange E, Kneba M, Stilgenbauer S, Döhner H, Hensel M, Kiehl MG, Jaeger U, Wendtner CM, Goede V, Fischer K, von Bergwelt-Baildon M, Eichhorst B, Hallek M, Theurich S.
Leukemia. 2020 Apr;34(4):1177-1181. doi: 10.1038/s41375-019-0630-6. Epub 2019 Nov 14. PMID: 31728057.



Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis.
Piechotta V, Jakob T, Langer P, Monsef I, Scheid C, Estcourt LJ, Ocheni S, Theurich S, Kuhr K, Scheckel B, Adams A, Skoetz N.
Cochrane Database Syst Rev. 2019 Nov 25;2019(11):CD013487. doi: 10.1002/14651858.CD013487. PMID: 31765002; PMCID: PMC6876545.

Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53.
Schuldner M, Dörsam B, Shatnyeva O, Reiners KS, Kubarenko A, Hansen HP, Finkernagel F, Roth K, Theurich S, Nist A, Stiewe T, Paschen A, Knittel G, Reinhardt HC, Müller R, Hallek M, von Strandmann EP.
Theranostics. 2019 Aug 14;9(21):6047-6062. doi: 10.7150/thno.36378. PMID: 31534536; PMCID: PMC6735508.

Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition.
Trommer M, Yeo SY, Persigehl T, Bunck A, Grüll H, Schlaak M, Theurich S, von Bergwelt-Baildon M, Morgenthaler J, Herter JM, Celik E, Marnitz S, Baues C.
Front Pharmacol. 2019 May 14;10:511. doi: 10.3389/fphar.2019.00511. Erratum in: Front Pharmacol. 2020 Jan 31;10:1615. PMID: 31156434; PMCID: PMC6530339.

Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma.
Lechner A, Schlößer HA, Thelen M, Wennhold K, Rothschild SI, Gilles R, Quaas A, Siefer OG, Huebbers CU, Cukuroglu E, Göke J, Hillmer A, Gathof B, Meyer MF, Klussmann JP, Shimabukuro-Vornhagen A, Theurich S, Beutner D, von Bergwelt-Baildon M.
Oncoimmunology. 2019 Jan 10;8(3):1535293. doi: 10.1080/2162402X.2018.1535293. PMID: 30723574; PMCID: PMC6350680.



Robotic Stereotactic Radiosurgery in Melanoma Patients with Brain Metastases under Simultaneous Anti-PD-1 Treatment.
Trommer-Nestler M, Marnitz S, Kocher M, Rueß D, Schlaak M, Theurich S, von Bergwelt-Baildon M, Morgenthaler J, Jablonska K, Celik E, Ruge MI, Baues C.
Int J Mol Sci. 2018 Sep 7;19(9):2653. doi: 10.3390/ijms19092653. PMID: 30205431; PMCID: PMC6164579.

Immuncheckpoint-Inhibitoren: Aktuelle Indikationen und mögliche zukünftige Konzepte [Immuncheckpoint Inhibitors: Current Indications and Possible Future Concepts].
Schlaak M, Baues C, Trommer-Nestler M, Berking C, Belka C, Theurich S.
Dtsch Med Wochenschr. 2018 Jul;143(14):1014-1021. German. doi: 10.1055/s-0043-125001. Epub 2018 Jul 13. PMID: 30005435.

Obesity exacerbates colitis-associated cancer via IL-6-regulated macrophage polarisation and CCL-20/CCR-6-mediated lymphocyte recruitment.
Wunderlich CM, Ackermann PJ, Ostermann AL, Adams-Quack P, Vogt MC, Tran ML, Nikolajev A, Waisman A, Garbers C, Theurich S, Mauer J, Hövelmeyer N, Wunderlich FT. 
Nat Commun. 2018 Apr 25;9(1):1646. doi: 10.1038/s41467-018-03773-0. PMID: 29695802; PMCID:



Serotonin Shapes the Migratory Potential of NK Cells - An in vitro Approach.
Zimmer P, Bloch W, Kieven M, Lövenich L, Lehmann J, Holthaus M, Theurich S, Schenk A.
Int J Sports Med. 2017 Oct;38(11):857-863. doi: 10.1055/s-0043-113042. Epub 2017 Aug 7. PMID: 28783845.

Using Antigen- Specific B Cells to Combine Antibody and T Cell-Based Cancer Immunotherapy.Wennhold K, Thelen M, Schlößer HA, Haustein N, Reuter S, Garcia-Marquez M, Lechner A, Kobold S, Rataj F, Utermöhlen O, Chakupurakal G, Theurich S, Hallek M, Abken H, Shimabukuro-Vornhagen A, von Bergwelt-Baildon M.
Cancer Immunol Res. 2017 Sep;5(9):730-743. doi: 10.1158/2326-6066.CIR-16-0236. Epub 2017 Aug 4. PMID: 28778961.

Should we be combining local tumor therapies with immunotherapies as standard?
Baues C, Schlaak M, von Bergwelt-Baildon M, Theurich S.
Future Oncol. 2017 Aug;13(18):1573-1575. doi: 10.2217/fon-2017-0150. Epub 2017 Aug 22. PMID: 28829189.

IL-6/Stat3-Dependent Induction of a Distinct, Obesity-Associated NK Cell Subpopulation Deteriorates Energy and Glucose Homeostasis.
Theurich S, Tsaousidou E, Hanssen R, Lempradl AM, Mauer J, Timper K, Schilbach K, Folz-Donahue K, Heilinger C, Sexl V, Pospisilik JA, Wunderlich FT, Brüning JC.
Cell Metab. 2017 Jul 5;26(1):171-184.e6. doi: 10.1016/j.cmet.2017.05.018. PMID: 28683285.

Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A, Schlößer H, Rothschild SI, Thelen M, Reuter S, Zentis P, Shimabukuro-Vornhagen A, Theurich S, Wennhold K, Garcia-Marquez M, Tharun L, Quaas A, Schauss A, Isensee J, Hucho T, Huebbers C, von Bergwelt-Baildon M, Beutner D.
Oncotarget. 2017 Jul 4;8(27):44418-44433. doi: 10.18632/oncotarget.17901. PMID: 28574843; PMCID: PMC5546490.

Temporal and tissue-specific requirements for T-lymphocyte IL-6 signalling in obesity-associated inflammation and insulin resistance.
Xu E, Pereira MMA, Karakasilioti I, Theurich S, Al-Maarri M, Rappl G, Waisman A, Wunderlich FT, Brüning JC.
Nat Commun. 2017 May 3;8:14803. doi: 10.1038/ncomms14803. PMID: 28466852; PMCID: PMC5418621.

CD40-activated B cells induce anti-tumor immunity in vivo.
Wennhold K, Weber TM, Klein-Gonzalez N, Thelen M, Garcia-Marquez M, Chakupurakal G, Fiedler A, Schlösser HA, Fischer R, Theurich S, Shimabukuro-Vornhagen A, von Bergwelt-Baildon M. 
Oncotarget. 2017 Apr 25;8(17):27740-27753. doi: 10.18632/oncotarget.7720. PMID: 26934557; PMCID: PMC5438605.

Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors.
Baues C, Trommer-Nestler M, Jablonska K, Bröckelmann PJ, Schlaak M, von Bergwelt-Baildon M, Engert A, Semrau R, Marnitz S, Theurich S.
Immunotherapy. 2017 Mar;9(5):423-433. doi: 10.2217/imt-2017-0002. PMID: 28357914.

Innovative Treatment Concepts for Cutaneous T-Cell Lymphoma Based on Microenvironment Modulation. Leuchte K, Schlaak M, Stadler R, Theurich S, von Bergwelt-Baildon M.
Oncol Res Treat. 2017;40(5):262-269. doi: 10.1159/000472257. Epub 2017 Apr 20. PMID: 28423378.



Regulatory B10 cells display an altered homoeostasis in acute graft-versus-host disease.
Chakupurakal G, Garcia-Marquez MA, Shimabukuro-Vornhagen A, Kluth S, Schlosser H, Theurich S, Scheid C, Hallek M, Holtick U, von Bergwelt-Baildon M.
Eur J Haematol. 2017 Feb;98(2):128-133. doi: 10.1111/ejh.12810. Epub 2016 Nov 6. PMID: 27717015.

Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity.
Jais A, Solas M, Backes H, Chaurasia B, Kleinridders A, Theurich S, Mauer J, Steculorum SM, Hampel B, Goldau J, Alber J, Förster CY, Eming SA, Schwaninger M, Ferrara N, Karsenty G, Brüning JC. 
Cell. 2016 Aug 25;166(5):1338-1340. doi: 10.1016/j.cell.2016.08.010. Erratum for: Cell. 2016 May 5;165(4):882-95. PMID: 27565353.

Antigen-presenting human B cells are expanded in inflammatory conditions.
Shimabukuro-Vornhagen A, García-Márquez M, Fischer RN, Iltgen-Breburda J, Fiedler A, Wennhold K, Rappl G, Abken H, Lehmann C, Herling M, Wolf D, Fätkenheuer G, Rubbert-Roth A, Hallek M, Theurich S, von Bergwelt-Baildon M.
J Leukoc Biol. 2017 Feb;101(2):577-587. doi: 10.1189/jlb.5A0416-182R. Epub 2016 Aug 17. PMID: 27534894.

Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma.
Theurich S, Rothschild SI, Hoffmann M, Fabri M, Sommer A, Garcia-Marquez M, Thelen M, Schill C, Merki R, Schmid T, Koeberle D, Zippelius A, Baues C, Mauch C, Tigges C, Kreuter A, Borggrefe J, von Bergwelt-Baildon M, Schlaak M.
Cancer Immunol Res. 2016 Sep 2;4(9):744-54. doi: 10.1158/2326-6066.CIR-15-0156. Epub 2016 Jul 27. PMID: 27466265.

Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity.
Jais A, Solas M, Backes H, Chaurasia B, Kleinridders A, Theurich S, Mauer J, Steculorum SM, Hampel B, Goldau J, Alber J, Förster CY, Eming SA, Schwaninger M, Ferrara N, Karsenty G, Brüning JC.
Cell. 2016 May 5;165(4):882-95. doi: 10.1016/j.cell.2016.03.033. Epub 2016 Apr 28. Erratum in: Cell. 2016 Aug 25;166(5):1338-1340. PMID: 27133169.

Physical exercise modulates the homeostasis of human regulatory T cells.
Weinhold M, Shimabukuro-Vornhagen A, Franke A, Theurich S, Wahl P, Hallek M, Schmidt A, Schinköthe T, Mester J, von Bergwelt-Baildon M, Bloch W.
J Allergy Clin Immunol. 2016 May;137(5):1607-1610.e8. doi: 10.1016/j.jaci.2015.10.035. Epub 2016 Jan 7. PMID: 26774657.

Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome-dependent cytosolic pathway in CD40-activated B cells.
Becker HJ, Kondo E, Shimabukuro-Vornhagen A, Theurich S, von Bergwelt-Baildon MS. 
Eur J Haematol. 2016 Aug;97(2):166-74. doi: 10.1111/ejh.12699. Epub 2015 Dec 10. PMID: 26561366.



Immunological effects in patients with steroid-refractory graft-versus-host disease following treatment with basiliximab, a CD25 monoclonal antibody.
Chakupurakal G, García-Márquez MA, Shimabukuro-Vornhagen A, Theurich S, Holtick U, Hallek M, Scheid C, von Bergwelt-Baildon M.
Eur J Haematol. 2016 Aug;97(2):121-7. doi: 10.1111/ejh.12691. Epub 2015 Nov 16. PMID: 26492560.

Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma.
Schlößer HA, Drebber U, Kloth M, Thelen M, Rothschild SI, Haase S, Garcia-Marquez M, Wennhold K, Berlth F, Urbanski A, Alakus H, Schauss A, Shimabukuro-Vornhagen A, Theurich S, Warnecke-Ebertz U, Stippel DL, Zippelius A, Büttner R, Hallek M, Hölscher AH, Zander T, Mönig SP, von Bergwelt-Baildon M. 
Oncoimmunology. 2015 Nov 9;5(5):e1100789. doi: 10.1080/2162402X.2015.1100789. PMID: 27467911; PMCID: PMC4910699.

FLAMSA reduced-intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remission.
Holtick U, Shimabukuro-Vornhagen A, Chakupurakal G, Theurich S, Leitzke S, Burst A, Hallek M, von Bergwelt-Baildon M, Scheid C, Chemnitz JM.
Eur J Haematol. 2016 May;96(5):475-82. doi: 10.1111/ejh.12615. Epub 2015 Aug 25. PMID: 26132980.

OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation.
Holtick U, Chemnitz JM, Shimabukuro-Vornhagen A, Theurich S, Chakupurakal G, Krause A, Fiedler A, Luznik L, Hellmich M, Wolf D, Hallek M, von Bergwelt-Baildon M, Scheid C. 
Eur J Haematol. 2016 Jan;96(1):27-35. doi: 10.1111/ejh.12541. Epub 2015 Mar 16. PMID: 25703164; PMCID: PMC4844370.

NK cells link obesity-induced adipose stress to inflammation and insulin resistance.
Wensveen FM, Jelenčić V, Valentić S, Šestan M, Wensveen TT, Theurich S, Glasner A, Mendrila D, Štimac D, Wunderlich FT, Brüning JC, Mandelboim O, Polić B.
Nat Immunol. 2015 Apr;16(4):376-85. doi: 10.1038/ni.3120. Epub 2015 Mar 2. PMID: 25729921.

Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults - a systematic review and meta-analysis.
Holtick U, Albrecht M, Chemnitz JM, Theurich S, Shimabukuro-Vornhagen A, Skoetz N, Scheid C, von Bergwelt-Baildon M.
Crit Rev Oncol Hematol. 2015 May;94(2):179-88. doi:10.1016/j.critrevonc.2014.12.007. Epub 2014 Dec 18. PMID: 25604498.



Multimerized form of recombinant human CD40 ligand supports long-term activation and proliferation of B cells.
Garcia-Marquez MA, Shimabukuro-Vornhagen A, Theurich S, Kochanek M, Weber T, Wennhold K, Dauben A, Dzionek A, Reinhard C, von Bergwelt-Baildon M. A
Cytotherapy. 2014 Nov;16(11):1537-1544. doi: 10.1016/j.jcyt.2014.05.011. PMID: 25287602.

Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma. 
Theurich S, Schlaak M, Steguweit H, Heukamp LC, Wennhold K, Kurschat P, Rabenhorst A, Hartmann K, Schlösser H, Shimabukuro-Vornhagen A, Holtick U, Hallek M, Stadler R, von Bergwelt-Baildon M.
J Clin Oncol. 2016 Apr 20;34(12):e110-6. doi: 10.1200/JCO.2013.50.9471. Epub 2014 Oct 27. PMID: 25348001.

Inhibition of protein geranylgeranylation specifically interferes with CD40-dependent B cell activation, resulting in a reduced capacity to induce T cell immunity.
Shimabukuro-Vornhagen A, Zoghi S, Liebig TM, Wennhold K, Chemitz J, Draube A, Kochanek M, Blaschke F, Pallasch C, Holtick U, Scheid C, Theurich S, Hallek M, von Bergwelt-Baildon MS. 
J Immunol. 2014 Nov 15;193(10):5294-305. doi: 10.4049/jimmunol.1203436. Epub 2014 Oct 13. PMID:

CD4+ T cell counts reflect the immunosuppressive state of CD4 helper cells in patients after allogeneic stem cell transplantation.
Holtick U, Frenzel LP, Shimabukuro-Vornhagen A, Theurich S, Claasen J, Scheid C, von Bergwelt-Baildon M, Fröhlich H, Wendtner CM, Chemnitz JM.
Ann Hematol. 2015 Jan;94(1):129-37. doi: 10.1007/s00277-014-2166-1. Epub 2014 Aug 15. PMID: 25118994.

Cancer chemotherapy agents target intratumoral dendritic cells to potentiate antitumor immunity.
Müller P, Martin K, Theurich S, von Bergwelt-Baildon M, Zippelius A. 
Oncoimmunology. 2014 Aug 3;3(8):e954460. doi: 10.4161/21624011.2014.954460. PMID: 25610745; PMCID: PMC4292760.

Characterization of tumor-associated B-cell subsets in patients with colorectal cancer.
Shimabukuro-Vornhagen A, Schlößer HA, Gryschok L, Malcher J, Wennhold K, Garcia-Marquez M, Herbold T, Neuhaus LS, Becker HJ, Fiedler A, Scherwitz P, Koslowsky T, Hake R, Stippel DL, Hölscher AH, Eidt S, Hallek M, Theurich S, von Bergwelt-Baildon MS.
Oncotarget. 2014 Jul 15;5(13):4651-64. doi: 10.18632/oncotarget.1701. PMID: 25026291; PMCID: PMC4148088.

Microtubule-depolymerizing agents used in antibody-drug conjugates induce antitumor immunity
by stimulation of dendritic cells.
Müller P, Martin K, Theurich S, Schreiner J, Savic S, Terszowski G, Lardinois D, Heinzelmann-Schwarz VA, Schlaak M, Kvasnicka HM, Spagnoli G, Dirnhofer S, Speiser DE, von Bergwelt-Baildon M, Zippelius A. 
Cancer Immunol Res. 2014 Aug;2(8):741-55. doi: 10.1158/2326-6066.CIR-13-0198. Epub 2014 Apr 21. PMID: 24916470.

Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
Holtick U, Albrecht M, Chemnitz JM, Theurich S, Skoetz N, Scheid C, von Bergwelt-Baildon M. Cochrane Database Syst Rev. 2014 Apr 20;(4):CD010189. doi: 10.1002/14651858.CD010189.pub2. PMID: 24748537.

Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-
associated resistance to insulin.
Mauer J, Chaurasia B, Goldau J, Vogt MC, Ruud J, Nguyen KD, Theurich S, Hausen AC, Schmitz J, Brönneke HS, Estevez E, Allen TL, Mesaros A, Partridge L, Febbraio MA, Chawla A, Wunderlich FT, Brüning JC.
Nat Immunol. 2014 May;15(5):423-30. doi: 10.1038/ni.2865. Epub 2014 Mar 30. PMID: 24681566; PMCID: PMC4161471.

Pretransplant comorbidities maintain their impact on allogeneic stem cell transplantation outcome 5 years posttransplant: a retrospective study in a single german institution.
Chemnitz JM, Chakupurakal G, Bäßler M, Holtick U, Theurich S, Shimabukuro-Vornhagen A, Leitzke S, Von Bergwelt-Baildon MS, Scheid C.
ISRN Hematol. 2014 Mar 5;2014:853435. doi: 10.1155/2014/853435. PMID: 24729881; PMCID: PMC3963108.

Overcoming tumor-mediated immunosuppression. Schlößer HA, Theurich S, Shimabukuro-Vornhagen A, Holtick U, Stippel DL, von Bergwelt-Baildon M.
Immunotherapy. 2014;6(9):973-88. doi: 10.2217/imt.14.58. PMID: 25341119.



Comment on "multiplex B cell characterization in blood, lymph nodes, and tumors from patients with malignancies".
Shimabukuro-Vornhagen A, Schlößer HA, Stippel DL, Theurich S, von Bergwelt-Baildon M.
J Immunol. 2013 Nov 1;191(9):4471. doi: 10.4049/jimmunol.1390052. PMID: 24141851.

Allogeneic stem cell transplantation in patients with aggressive primary cutaneous T-cell lymphoma - a case series of the ADF working group "cutaneous lymphomas".
Moritz RK, Ditschkowski M, Klemke CD, Terras S, Schlaak M, Knorr M, Theurich S, Hegenbart U, Kremens B, Beelen DW, Stücker M, Kreuter A; working group "cutaneous lymphomas" of the Arbeitsgemeinschaft für Dermatologische Forschung (ADF), Germany.
J Dtsch Dermatol Ges. 2014 Jan;12(1):39-46. doi: 10.1111/ddg.12212. Epub 2013 Oct 17. PMID: 24134607.

Vaccination with dendritic cell-tumor fusion cells in multiple myeloma patients: a promising strategy?
Garcia-Marquez MA, Shimabukuro-Vornhagen A, Theurich S, von Bergwelt-Baildon
M. Immunotherapy. 2013 Oct;5(10):1039-42. doi: 10.2217/imt.13.96. PMID: 24088074.

Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma.
Schlaak M, Pickenhain J, Theurich S, Skoetz N, von Bergwelt-Baildon M, Kurschat P.
Cochrane Database Syst Rev. 2013 Aug 29;2013(8):CD008908. doi: 10.1002/14651858.CD008908.pub3. PMID: 23986525; PMCID: PMC7156921.

CD30-targeted therapy with brentuximab vedotin and DLI in a patient with T-cell posttransplantation
lymphoma: induction of clinical remission and cellular immunity.
Theurich S, Wennhold K, Wedemeyer I, Rothe A, Hübel K, Shimabukuro-Vornhagen A, Holtick U, Hallek M, Scheid C, von Bergwelt-Baildon M.
Transplantation. 2013 Aug 15;96(3):e16-8. doi: 10.1097/TP.0b013e31829a9258. PMID: 23917689.

18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to
brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphoma.
Kahraman D, Theurich S, Rothe A, Kuhnert G, Sasse S, Scheid C, Dietlein M, Drzezga A, von Bergwelt-Baildon M, Kobe C.
Leuk Lymphoma. 2014 Apr;55(4):811-6. doi: 10.3109/10428194.2013.819575. Epub 2013 Jul 29. PMID: 23805904.

CD40-activated B cells as antigen-presenting cells: the final sprint toward clinical application.
Wennhold K, Shimabukuro-Vornhagen A, Theurich S, von Bergwelt-Baildon M.
Expert Rev Vaccines. 2013 Jun;12(6):631-7. doi: 10.1586/erv.13.39. PMID: 23750793.

Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis-A systematic review and meta-analysis.
Theurich S, Fischmann H, Chakupurakal G, Shimabukuro-Vornhagen A, Chemnitz JM, Holtick U, Rothe A, Scheid C, Hallek M, Skoetz N, von Bergwelt-Baildon M.
Crit Rev Oncol Hematol. 2013 Oct;88(1):178-86. doi: 10.1016/j.critrevonc.2013.03.009. Epub 2013 Apr 2. PMID: 23561334.

Cyclin A1, a promising tumor antigen: the devil is in the amino acids.
Wennhold K, Theurich S, von Bergwelt-Baildon M.
Expert Rev Anticancer Ther. 2013 Mar;13(3):243-5. doi: 10.1586/era.12.175. PMID: 23477508.

The ratio between dendritic cells and T cells determines whether prostaglandin E2 has a stimulatory or inhibitory effect.
Shimabukuro-Vornhagen A, Liebig TM, Koslowsky T, Theurich S, von Bergwelt-Baildon MS. 
Cell Immunol. 2013 Jan;281(1):62-7. doi: 10.1016/j.cellimm.2013.01.001. Epub 2013 Jan 29. PMID: 23454682



Brentuximab vedotin combined with donor lymphocyte infusions for early relapse of Hodgkin lymphoma after allogeneic stem-cell transplantation induces tumor-specific immunity and sustained clinical remission.
Theurich S, Malcher J, Wennhold K, Shimabukuro-Vornhagen A, Chemnitz J, Holtick U, Krause A, Kobe C, Kahraman D, Engert A, Scheid C, Chakupurakal G, Hallek M, von Bergwelt-Baildon M.
J Clin Oncol. 2013 Feb 10;31(5):e59-63. doi: 10.1200/JCO.2012.43.6832. Epub 2012 Dec 26. PMID: 23269992.

Allogeneic hematopoietic stem cell transplantation: an option for long-term survival for patients with simultaneous appearance of myeloid and lymphatic malignancies.
Weber T, Ocheni S, Binder M, Theurich S, Scheid C, Schmid C, Müller LP, Christopeit M, Bacher U.
Acta Haematol. 2013;129(3):135-6. doi: 10.1159/000343422. Epub 2012 Nov 29. PMID: 23207834.

Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.
Theurich S, Fischmann H, Shimabukuro-Vornhagen A, Chemnitz JM, Holtick U, Scheid C, Skoetz N, von Bergwelt-Baildon M.
Cochrane Database Syst Rev. 2012 Sep 12;(9):CD009159. doi: 10.1002/14651858.CD009159.pub2. PMID: 22972135.

Mast cells play a protumorigenic role in primary cutaneous lymphoma.
Rabenhorst A, Schlaak M, Heukamp LC, Förster A, Theurich S, von Bergwelt-Baildon M, Büttner R, Kurschat P, Mauch C, Roers A, Hartmann K.
Blood. 2012 Sep 6;120(10):2042-54. doi: 10.1182/blood-2012-03-415638. Epub 2012 Jul 26. PMID: 22837530.

Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experience.
Rothe A, Sasse S, Goergen H, Eichenauer DA, Lohri A, Jäger U, Bangard C, Böll B, von Bergwelt Baildon M, Theurich S, Borchmann P, Engert A. 
Blood. 2012 Aug 16;120(7):1470-2. doi: 10.1182/blood-2012-05-430918. Epub 2012 Jul 11. Erratum in: Blood. 2014 Aug 14;124(7):1201. PMID: 22786877.

Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma.Schlaak M, Pickenhain J, Theurich S, Skoetz N, von Bergwelt-Baildon M, Kurschat P. 
Cochrane Database Syst Rev. 2012 Jan 18;1:CD008908. doi: 10.1002/14651858.CD008908.pub2. Update in: Cochrane Database Syst Rev. 2013;8:CD008908. PMID: 22258991.



Activated primary human B cells efficiently induce early CD40L and CD107a expression in CD4+ T cells.
Theurich S, Malcher J, Becker HJ, Chemnitz JM, Liebig TM, Shimabukuro-Vornhagen A, von Bergwelt-Baildon M.
Blood. 2011 Nov 24;118(22):5979-80. doi: 10.1182/blood-2011-05-356683. PMID: 22123910.

Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG
for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia.
Chemnitz JM, von Lilienfeld-Toal M, Holtick U, Theurich S, Shimabukuro-Vornhagen A, Krause A, Brossart P, Hallek M, Scheid C. 
Ann Hematol. 2012 Jan;91(1):47-55. doi: 10.1007/s00277-011-1253-9. Epub 2011 May 17. PMID: 21584670.


2009 and before

Rituximab reduces the incidence of acute graft-versus-host disease.
Christopeit M, Schütte V, Theurich S, Weber T, Grothe W, Behre G. 
Blood. 2009 Mar 26;113(13):3130-1. doi: 10.1182/blood-2009-01-200527. PMID: 19324911.

Successful treatment of severe sinusoidal obstruction syndrome despite multiple organ failure with defibrotide after allogeneic stem cell transplantation: a case report.
Behre G, Theurich S, Christopeit M, Weber T.
J Med Case Rep. 2009 Mar 10;3:6164. doi: 10.4076/1752-1947-3-6164. PMID: 19830097; PMCID: PMC2726490.

Graft-versus-lymphoma effect in a 64-year-old caucasian woman after allogeneic stem-cell transplantation: a case report.
Behre G, Weber T, Theurich S, Christopeit M.
J Med Case Rep. 2009 Jan 13;3:10. doi: 10.1186/1752-1947-3-10. PMID: 19144104; PMCID: PMC2647932.


Neurotoxicity upon infusion of dimethylsulfoxide-cryopreserved peripheral blood stem cells in patients with and without pre-existing cerebral disease.
Mueller LP, Theurich S, Christopeit M, Grothe W, Muetherig A, Weber T, Guenther S, Behre G.
Eur J Haematol. 2007 Jun;78(6):527-31. doi: 10.1111/j.1600-0609.2007.00851.x. PMID: 17509106.

Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma.
Stühmer T, Chatterjee M, Hildebrandt M, Herrmann P, Gollasch H, Gerecke C, Theurich S, Cigliano L, Manz RA, Daniel PT, Bommert K, Vassilev LT, Bargou RC.
Blood. 2005 Nov 15;106(10):3609-17. doi: 10.1182/blood-2005-04-1489. Epub 2005 Aug 4. PMID: 16081689.

Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells.
Emmerich F, Theurich S, Hummel M, Haeffker A, Vry MS, Döhner K, Bommert K, Stein H, Dörken B. 
J Pathol. 2003 Nov;201(3):413-20. doi: 10.1002/path.1454. PMID: 14595753.